Back to Results
First PageMeta Content
Orphan drugs / Pharmacology / Health economics / Organofluorides / Kidney cancer / Xyrem / Sunitinib / Pharmacoeconomics / Deferasirox / Medicine / Chemistry / Health


Challenge of HTA and Pharmacoeconomics for Rare Disorders
Add to Reading List

Document Date: 2009-04-08 12:55:11

Open Document

File Size: 2,40 MB

Share Result on Facebook

City

Overload)e Evidence / /

Company

Case (Kidney Cancer) Limited / Case / PhD / /

Country

Canada / /

Currency

USD / /

MedicalCondition

Rare Disorders / Cancer / disease / II Narcolepsy MDS / Iron Overload / Metabolic Disorders / Cystic Fibrosis / rare disease / Kidney Cancer / Pulmonary Hypertension / /

Organization

FDA / Canadian Organization for Rare Disorders / /

Person

Exjade Nexavar Sutent / Disorders Durhane Wong-Rieger / /

Position

Physician / President / /

Product

Soliris / Myozyme / zavesca / somavert / EXJADE / Revlimid / Xyrem / FABRAZYME / Sutent / NEXAVAR / Elaprase / Aldurazyme / /

SocialTag